Karen Jane Russell

Karen Jane Russell

Active Director Director DIN 08458357
DIN 08458357 First appointment Jun 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Karen Jane Russell

Data last updated:

Karen Jane Russell is a Director at Worldwide Clinical Trials India Private Limited (since 2019). The company operates in Pharma. Worldwide Clinical Trials India Private Limited reported revenue of ₹1.07 Cr (FY 2025).

DIN 08458357
Primary Designation Director
Industry Pharma
First Appointment 20 Jun 2019
Oldest Company Age 14 yrs
Largest company Worldwide Clinical Trials India Private Limited · ₹1.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jun 20192012₹1.07 Cr (FY 2025)Active

Board colleagues of Karen Jane Russell

Directorship timeline

Open interactive timeline →
Worldwide Clinical Trials India Private Limited
Premium access

Shareholding and investment profile for Karen Jane Russell

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karen Jane Russell

Karen Jane Russell currently holds 1 directorship: Worldwide Clinical Trials India Private Limited (Director, since 20 Jun 2019, revenue ₹1.07 Cr (FY 2025)).

Karen Jane Russell was first appointed on 20 Jun 2019 as Director at Worldwide Clinical Trials India Private Limited.

The current boards of Karen Jane Russell's companies include Vishal Lochan Aggarwal (Worldwide Clinical Trials India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available